Arcutis Biotherapeutics, Inc. (ARQT)
23.88
+0.50
(+2.16%)
USD |
NASDAQ |
Sep 11, 16:00
23.89
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price to Book Value : 13.60 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 13.60 |
| September 10, 2026 | 13.31 |
| September 09, 2026 | 13.57 |
| September 08, 2026 | 13.89 |
| September 04, 2026 | 13.61 |
| September 03, 2026 | 13.47 |
| September 02, 2026 | 13.58 |
| September 01, 2026 | 13.52 |
| August 31, 2026 | 13.65 |
| August 28, 2026 | 13.54 |
| August 27, 2026 | 14.16 |
| August 26, 2026 | 14.31 |
| August 25, 2026 | 14.15 |
| August 24, 2026 | 14.11 |
| August 21, 2026 | 14.28 |
| August 20, 2026 | 14.43 |
| August 19, 2026 | 15.07 |
| August 18, 2026 | 15.11 |
| August 17, 2026 | 14.58 |
| August 14, 2026 | 14.91 |
| August 13, 2026 | 14.71 |
| August 12, 2026 | 14.96 |
| August 11, 2026 | 14.93 |
| August 10, 2026 | 14.76 |
| August 07, 2026 | 14.40 |
| Date | Value |
|---|---|
| August 06, 2026 | 15.05 |
| August 05, 2026 | 15.43 |
| August 04, 2026 | 14.82 |
| August 03, 2026 | 14.77 |
| July 31, 2026 | 15.29 |
| July 30, 2026 | 15.94 |
| July 29, 2026 | 15.86 |
| July 28, 2026 | 16.18 |
| July 27, 2026 | 15.85 |
| July 24, 2026 | 15.57 |
| July 23, 2026 | 15.56 |
| July 22, 2026 | 15.89 |
| July 21, 2026 | 16.09 |
| July 20, 2026 | 15.67 |
| July 17, 2026 | 16.22 |
| July 16, 2026 | 15.79 |
| July 15, 2026 | 15.82 |
| July 14, 2026 | 15.26 |
| July 13, 2026 | 15.44 |
| July 10, 2026 | 15.79 |
| July 09, 2026 | 16.39 |
| July 08, 2026 | 16.23 |
| July 07, 2026 | 15.75 |
| July 06, 2026 | 14.84 |
| July 02, 2026 | 14.70 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Insmed, Inc. | 37.29 |
| Emergent BioSolutions, Inc. | 0.9361 |
| Exelixis, Inc. | 7.576 |
| Vertex Pharmaceuticals, Inc. | 6.449 |
Price to Book Value Related Metrics
| PE Ratio | 115.33 |
| PS Ratio | 6.870 |
| Price to Free Cash Flow | 81.41 |
| Price | 23.88 |
| Earnings Yield | 0.87% |
| Market Cap | 3.000B |
| Operating PE Ratio | 93.05 |
| Normalized PE Ratio | 115.11 |